Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Netflix
NFLX
|
+$385M |
| 2 |
Microsoft
MSFT
|
+$368M |
| 3 |
Berkshire Hathaway Class A
BRK.A
|
+$298M |
| 4 |
Delta Air Lines
DAL
|
+$208M |
| 5 |
Carnival Corporation Ltd
CCL
|
+$203M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$1.34B |
| 2 |
Tesla
TSLA
|
+$353M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$303M |
| 4 |
NVIDIA
NVDA
|
+$290M |
| 5 |
Boeing
BA
|
+$286M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.37% |
| 2 | Healthcare | 18.47% |
| 3 | Consumer Discretionary | 12.41% |
| 4 | Consumer Staples | 10.13% |
| 5 | Industrials | 9.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ARCE
1801
DELISTED
Arco Platform Limited Class A Common Shares
ARCE
| $2.2M | ﹤0.01% |
+159,900
| New | +$2.11M |
|
|
FM
1802
DELISTED
iShares Frontier and Select EM ETF
FM
| $2.2M | ﹤0.01% |
85,000
+8,200
| +11% | +$221K |
|
1803
Viemed Healthcare
VMD
$350M
| $2.2M | ﹤0.01% |
326,700
+82,400
| +34% | +$675K |
|
|
ALE
1804
DELISTED
Allete
ALE
| $2.2M | ﹤0.01% |
41,599
+3,000
| +8% | +$169K |
|
1805
Winnebago Industries
WGO
$892M
| $2.19M | ﹤0.01% |
+36,900
| New | +$2.39M |
|
1806
MarineMax
HZO
$1.15B
| $2.19M | ﹤0.01% |
+66,714
| New | +$2.32M |
|
1807
Southern First Bancshares
SFST
$608M
| $2.19M | ﹤0.01% |
81,207
+1,200
| +1% | +$33.3K |
|
1808
Atlas Energy Solutions
AESI
$1.56B
| $2.19M | ﹤0.01% |
98,400
+7,700
| +8% | +$161K |
|
|
USAP
1809
DELISTED
Universal Stainless & Alloy
USAP
| $2.19M | ﹤0.01% |
166,758
+30,658
| +23% | +$431K |
|
|
PNT
1810
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
| $2.18M | ﹤0.01% |
327,271
+136,296
| +71% | +$1.13M |
|
1811
Victory Capital Holdings
VCTR
$7.27B
| $2.18M | ﹤0.01% |
65,400
+22,200
| +51% | +$741K |
|
1812
Universal Insurance Holdings
UVE
$1.2B
| $2.18M | ﹤0.01% |
155,200
+131,312
| +550% | +$1.84M |
|
1813
Organogenesis Holdings
ORGO
$230M
| $2.17M | ﹤0.01% |
684,094
-22,008
| -3% | -$69.9K |
|
1814
Assured Guaranty
AGO
$3.38B
| $2.17M | ﹤0.01% |
35,900
-89,600
| -71% | -$5.32M |
|
1815
State Street SPDR S&P Regional Banking ETF
KRE
$4.68B
| $2.17M | ﹤0.01% |
+52,000
| New | +$2.32M |
|
1816
Mirum Pharmaceuticals
MIRM
$6.14B
| $2.17M | ﹤0.01% |
68,700
+57,100
| +492% | +$1.56M |
|
|
FIRY
1817
Firy Inc
FIRY
$148M
| $2.17M | ﹤0.01% |
424,725
+82,400
| +24% | +$732K |
|
1818
Anterix
ATEX
$1.79B
| $2.16M | ﹤0.01% |
+68,900
| New | +$2.17M |
|
1819
Bowman Consulting
BWMN
$733M
| $2.15M | ﹤0.01% |
76,821
-60,279
| -44% | -$1.84M |
|
1820
CION Investment
CION
$370M
| $2.15M | ﹤0.01% |
203,400
-82,688
| -29% | -$895K |
|
|
MAXN
1821
DELISTED
Maxeon Solar Technologies
MAXN
| $2.15M | ﹤0.01% |
1,852
-1,845
| -50% | -$3.51M |
|
1822
NatWest
NWG
$76B
| $2.14M | ﹤0.01% |
366,400
+73,600
| +25% | +$445K |
|
1823
Merit Medical Systems
MMSI
$5.42B
| $2.13M | ﹤0.01% |
30,912
-24,800
| -45% | -$1.78M |
|
1824
Integer Holdings
ITGR
$4.26B
| $2.13M | ﹤0.01% |
+27,200
| New | +$2.3M |
|
1825
Interface
TILE
$2.19B
| $2.13M | ﹤0.01% |
217,200
+23,000
| +12% | +$223K |
|
Similar funds
Jim Simons's Q3 2023 Portfolio in Review
As of Q3 2023, Jim Simons held 4,329 positions worth $58.7B, down 15% from $69.4B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Jim Simons withdrew a net $8.34B in Q3 2023, closing 713 positions and reducing 1,794 holdings. Its most notable exit was Chevron, an estimated $185M position sold in full.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Jim Simons opened a new position in D.R. Horton worth $125M.
- Jim Simons's largest Q3 2023 buy was D.R. Horton: 1,159,438 shares worth $125M.
- Jim Simons added most to Netflix in Q3 2023, an estimated $385M increase.
- Jim Simons's biggest Q3 2023 reduction was Meta Platforms (Facebook), cutting an estimated $1.34B.
- Jim Simons fully exited Chevron in Q3 2023, selling an estimated $185M.
- Jim Simons's ten largest holdings make up 12% of its $58.7B portfolio in Q3 2023.
- Jim Simons opened 464 new positions and closed 713 in Q3 2023.
- Jim Simons's portfolio value fell 15% quarter-over-quarter to $58.7B.
Based on Renaissance Technologies's 13F filing for Q3 2023, filed 14 Nov 2023.